Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Perspectives for Applying G-Quadruplex Structures in Neurobiology and Neuropharmacology.

Asamitsu S, Takeuchi M, Ikenoshita S, Imai Y, Kashiwagi H, Shioda N.

Int J Mol Sci. 2019 Jun 13;20(12). pii: E2884. doi: 10.3390/ijms20122884. Review.

2.

Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels.

Fukunaga K, Izumi H, Yabuki Y, Shinoda Y, Shioda N, Han F.

J Pharmacol Sci. 2019 Feb;139(2):51-58. doi: 10.1016/j.jphs.2018.11.014. Epub 2018 Dec 18. Review.

3.

Different PDGF Receptor Dimers Drive Distinct Migration Modes of the Mouse Skin Fibroblast.

Yamada K, Hamashima T, Ishii Y, Yamamoto S, Okuno N, Yoshida N, Yamada M, Huang TT, Shioda N, Tomihara K, Fujimori T, Mori H, Fukunaga K, Noguchi M, Sasahara M.

Cell Physiol Biochem. 2018;51(3):1461-1479. doi: 10.1159/000495594. Epub 2018 Nov 28.

4.

SA4503, A Potent Sigma-1 Receptor Ligand, Ameliorates Synaptic Abnormalities and Cognitive Dysfunction in a Mouse Model of ATR-X Syndrome.

Yamaguchi K, Shioda N, Yabuki Y, Zhang C, Han F, Fukunaga K.

Int J Mol Sci. 2018 Sep 18;19(9). pii: E2811. doi: 10.3390/ijms19092811.

5.

Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome.

Shioda N, Yabuki Y, Yamaguchi K, Onozato M, Li Y, Kurosawa K, Tanabe H, Okamoto N, Era T, Sugiyama H, Wada T, Fukunaga K.

Nat Med. 2018 Jun;24(6):802-813. doi: 10.1038/s41591-018-0018-6. Epub 2018 May 21.

PMID:
29785027
6.

Identification of Two Phenanthrene Derivatives from Australasian Allied Species in Genus Dendrobium.

Takamiya T, Kitamura S, Suzuki S, Shioda N, Matsuo Y, Murase K, Kaiho Y, Tsurumaki Y, Fujiwara Y, Sone M, Machida T, Matsumoto R, Miyamoto A, Hirose D, Furukawa M, Makino M, Matsuzaki K, Kitanaka S, Yukawa T, Iijima H.

Chem Pharm Bull (Tokyo). 2018 Jun 1;66(6):642-650. doi: 10.1248/cpb.c18-00076. Epub 2018 Apr 5.

7.

Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect.

Tamura S, Okada M, Kato S, Shinoda Y, Shioda N, Fukunaga K, Ui-Tei K, Ueda M.

Sci Rep. 2018 Feb 2;8(1):2305. doi: 10.1038/s41598-018-20663-z.

8.

Physiological and Pathological Roles of CaMKII-PP1 Signaling in the Brain.

Shioda N, Fukunaga K.

Int J Mol Sci. 2017 Dec 22;19(1). pii: E20. doi: 10.3390/ijms19010020. Review.

9.

[Involvement of G-quadruplexes in neurodegenerative diseases].

Shioda N.

Nihon Yakurigaku Zasshi. 2017;150(6):298. doi: 10.1254/fpj.150.298. Japanese. No abstract available.

PMID:
29225293
10.

Dopamine D2L receptor-interacting proteins regulate dopaminergic signaling.

Shioda N.

J Pharmacol Sci. 2017 Oct 14. pii: S1347-8613(17)30171-8. doi: 10.1016/j.jphs.2017.10.002. [Epub ahead of print] Review.

11.

RNA toxicity and RAN translation in repeat expansion disorders.

Shioda N.

Nihon Yakurigaku Zasshi. 2017;150(3):165. doi: 10.1254/fpj.150.165. Japanese. No abstract available.

PMID:
28890479
12.

Endocytosis following dopamine D2 receptor activation is critical for neuronal activity and dendritic spine formation via Rabex-5/PDGFRβ signaling in striatopallidal medium spiny neurons.

Shioda N, Yabuki Y, Wang Y, Uchigashima M, Hikida T, Sasaoka T, Mori H, Watanabe M, Sasahara M, Fukunaga K.

Mol Psychiatry. 2017 Aug;22(8):1205-1222. doi: 10.1038/mp.2016.200. Epub 2016 Dec 6.

PMID:
27922607
13.

Blockade of the KATP channel Kir6.2 by memantine represents a novel mechanism relevant to Alzheimer's disease therapy.

Moriguchi S, Ishizuka T, Yabuki Y, Shioda N, Sasaki Y, Tagashira H, Yawo H, Yeh JZ, Sakagami H, Narahashi T, Fukunaga K.

Mol Psychiatry. 2018 Feb;23(2):211-221. doi: 10.1038/mp.2016.187. Epub 2016 Oct 25.

PMID:
27777420
14.

Effect of ATRX and G-Quadruplex Formation by the VNTR Sequence on α-Globin Gene Expression.

Li Y, Syed J, Suzuki Y, Asamitsu S, Shioda N, Wada T, Sugiyama H.

Chembiochem. 2016 May 17;17(10):928-35. doi: 10.1002/cbic.201500655. Epub 2016 Apr 20.

PMID:
26991472
15.

Nuclear Translocation of Calcium/Calmodulin-dependent Protein Kinase IIδ3 Promoted by Protein Phosphatase-1 Enhances Brain-derived Neurotrophic Factor Expression in Dopaminergic Neurons.

Shioda N, Sawai M, Ishizuka Y, Shirao T, Fukunaga K.

J Biol Chem. 2015 Aug 28;290(35):21663-75. doi: 10.1074/jbc.M115.664920. Epub 2015 Jul 10.

16.

Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulation.

Yabuki Y, Shinoda Y, Izumi H, Ikuno T, Shioda N, Fukunaga K.

Brain Res. 2015 Oct 5;1622:102-13. doi: 10.1016/j.brainres.2015.05.006. Epub 2015 Jun 25.

PMID:
26119915
17.

[Molecular mechanisms of synapse pathology in ATR-X syndrome].

Shioda N, Fukunaga K.

Nihon Yakurigaku Zasshi. 2015 Apr;145(4):174-7. doi: 10.1254/fpj.145.174. Japanese. No abstract available.

PMID:
25864826
18.

Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosis.

Tagashira H, Shinoda Y, Shioda N, Fukunaga K.

Biochim Biophys Acta. 2014 Dec;1840(12):3320-34. doi: 10.1016/j.bbagen.2014.08.012. Epub 2014 Aug 29.

PMID:
25175561
19.

Molecular phylogenetics and character evolution of morphologically diverse groups, Dendrobium section Dendrobium and allies.

Takamiya T, Wongsawad P, Sathapattayanon A, Tajima N, Suzuki S, Kitamura S, Shioda N, Handa T, Kitanaka S, Iijima H, Yukawa T.

AoB Plants. 2014 Aug 7;6. pii: plu045. doi: 10.1093/aobpla/plu045.

20.

FABP3 protein promotes α-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity.

Shioda N, Yabuki Y, Kobayashi Y, Onozato M, Owada Y, Fukunaga K.

J Biol Chem. 2014 Jul 4;289(27):18957-65. doi: 10.1074/jbc.M113.527341. Epub 2014 May 22.

21.

Aberrant CaMKII activity in the medial prefrontal cortex is associated with cognitive dysfunction in ADHD model rats.

Yabuki Y, Shioda N, Maeda T, Hiraide S, Togashi H, Fukunaga K.

Brain Res. 2014 Apr 4;1557:90-100. doi: 10.1016/j.brainres.2014.02.025. Epub 2014 Feb 19.

PMID:
24561222
22.

Fluvoxamine rescues mitochondrial Ca2+ transport and ATP production through σ(1)-receptor in hypertrophic cardiomyocytes.

Tagashira H, Bhuiyan MS, Shioda N, Fukunaga K.

Life Sci. 2014 Jan 30;95(2):89-100. doi: 10.1016/j.lfs.2013.12.019. Epub 2013 Dec 25.

PMID:
24373833
23.
24.

Oral L-citrulline administration improves memory deficits following transient brain ischemia through cerebrovascular protection.

Yabuki Y, Shioda N, Yamamoto Y, Shigano M, Kumagai K, Morita M, Fukunaga K.

Brain Res. 2013 Jul 3;1520:157-67. doi: 10.1016/j.brainres.2013.05.011. Epub 2013 May 16.

PMID:
23685189
25.

AP-1B-mediated protein sorting regulates polarity and proliferation of intestinal epithelial cells in mice.

Hase K, Nakatsu F, Ohmae M, Sugihara K, Shioda N, Takahashi D, Obata Y, Furusawa Y, Fujimura Y, Yamashita T, Fukuda S, Okamoto H, Asano M, Yonemura S, Ohno H.

Gastroenterology. 2013 Sep;145(3):625-35. doi: 10.1053/j.gastro.2013.05.013. Epub 2013 May 16.

PMID:
23684748
26.

Novel cognitive enhancer ST101 enhances acetylcholine release in mouse dorsal hippocampus through T-type voltage-gated calcium channel stimulation.

Yamamoto Y, Shioda N, Han F, Moriguchi S, Fukunaga K.

J Pharmacol Sci. 2013;121(3):212-26. Epub 2013 Mar 1.

27.

Decreased CaMKII and PKC activities in specific brain regions are associated with cognitive impairment in neonatal ventral hippocampus-lesioned rats.

Yabuki Y, Nakagawasai O, Moriguchi S, Shioda N, Onogi H, Tan-No K, Tadano T, Fukunaga K.

Neuroscience. 2013 Mar 27;234:103-15. doi: 10.1016/j.neuroscience.2012.12.048. Epub 2013 Jan 8.

PMID:
23313709
28.

Expression of a truncated form of the endoplasmic reticulum chaperone protein, σ1 receptor, promotes mitochondrial energy depletion and apoptosis.

Shioda N, Ishikawa K, Tagashira H, Ishizuka T, Yawo H, Fukunaga K.

J Biol Chem. 2012 Jul 6;287(28):23318-31. doi: 10.1074/jbc.M112.349142. Epub 2012 May 22.

29.

[Abnormal dendritic spine morphology and its signal transduction mechanisms in mental retardation].

Shioda N, Fukunaga K.

Seikagaku. 2011 Dec;83(12):1113-7. Review. Japanese. No abstract available.

PMID:
22352041
30.

The T-type voltage-gated calcium channel as a molecular target of the novel cognitive enhancer ST101: enhancement of long-term potentiation and CaMKII autophosphorylation in rat cortical slices.

Moriguchi S, Shioda N, Yamamoto Y, Tagashira H, Fukunaga K.

J Neurochem. 2012 Apr;121(1):44-53. doi: 10.1111/j.1471-4159.2012.07667.x. Epub 2012 Feb 3.

31.

Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop.

Fukunaga K, Shioda N.

Mol Neurobiol. 2012 Feb;45(1):144-52. doi: 10.1007/s12035-011-8227-8. Epub 2011 Dec 20. Review.

PMID:
22183739
32.

Aberrant hippocampal spine morphology and impaired memory formation in neuronal platelet-derived growth factor β-receptor lacking mice.

Shioda N, Moriguchi S, Oya T, Ishii Y, Shen J, Matsushima T, Nishijo H, Sasahara M, Fukunaga K.

Hippocampus. 2012 Jun;22(6):1371-8. doi: 10.1002/hipo.20973. Epub 2011 Oct 13.

PMID:
21997856
33.

CaMKIIδB mediates aberrant NCX1 expression and the imbalance of NCX1/SERCA in transverse aortic constriction-induced failing heart.

Lu YM, Huang J, Shioda N, Fukunaga K, Shirasaki Y, Li XM, Han F.

PLoS One. 2011;6(9):e24724. doi: 10.1371/journal.pone.0024724. Epub 2011 Sep 13.

34.

Distinct cardioprotective effects of 17β-estradiol and dehydroepiandrosterone on pressure overload-induced hypertrophy in ovariectomized female rats.

Tagashira H, Bhuiyan S, Shioda N, Fukunaga K.

Menopause. 2011 Dec;18(12):1317-26. doi: 10.1097/gme.0b013e31821f915b.

PMID:
21844826
35.

[Dopamine D2 receptor as a novel target molecule for heart-type fatty acid binding protein].

Shioda N, Yamamoto Y, Owada Y, Fukunaga K.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Jun;31(3):125-30. Japanese.

PMID:
21800703
36.

Identification of dendrobium species used for herbal medicines based on ribosomal DNA internal transcribed spacer sequence.

Takamiya T, Wongsawad P, Tajima N, Shioda N, Lu JF, Wen CL, Wu JB, Handa T, Iijima H, Kitanaka S, Yukawa T.

Biol Pharm Bull. 2011;34(5):779-82.

37.

[Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior].

Shioda N, Yamamoto Y, Han F, Moriguchi S, Fukunaga K.

Yakugaku Zasshi. 2011 Apr;131(4):505-11. Review. Japanese.

38.

[Regulation of dopaminergic neuronal activity by heart-type fatty acid binding protein in the brain].

Yamamoto Y, Shioda N, Owada Y, Fukunaga K.

Yakugaku Zasshi. 2011 Apr;131(4):497-501. Review. Japanese. Erratum in: Yakugaku Zasshi. 2011;131(5):862.

39.

[Functional roles of constitutively active calcineurin in delayed neuronal death after brain ischemia].

Shioda N, Fukunaga K.

Yakugaku Zasshi. 2011 Jan;131(1):13-20. Review. Japanese.

40.

Aberrant calcium/calmodulin-dependent protein kinase II (CaMKII) activity is associated with abnormal dendritic spine morphology in the ATRX mutant mouse brain.

Shioda N, Beppu H, Fukuda T, Li E, Kitajima I, Fukunaga K.

J Neurosci. 2011 Jan 5;31(1):346-58. doi: 10.1523/JNEUROSCI.4816-10.2011.

41.

Reduced expression of the ATRX gene, a chromatin-remodeling factor, causes hippocampal dysfunction in mice.

Nogami T, Beppu H, Tokoro T, Moriguchi S, Shioda N, Fukunaga K, Ohtsuka T, Ishii Y, Sasahara M, Shimada Y, Nishijo H, Li E, Kitajima I.

Hippocampus. 2011 Jun;21(6):678-87. doi: 10.1002/hipo.20782. Epub 2010 Mar 15.

PMID:
20865721
42.

CaMKII phosphorylates serine 10 of p27 and confers apoptosis resistance to HeLa cells.

Kajihara R, Fukushige S, Shioda N, Tanabe K, Fukunaga K, Inui S.

Biochem Biophys Res Commun. 2010 Oct 22;401(3):350-5. doi: 10.1016/j.bbrc.2010.09.051. Epub 2010 Sep 17.

PMID:
20851109
43.

Ca2+/calmodulin-dependent protein kinase II and protein kinase C activities mediate extracellular glucose-regulated hippocampal synaptic efficacy.

Moriguchi S, Oomura Y, Shioda N, Han F, Hori N, Aou S, Fukunaga K.

Mol Cell Neurosci. 2011 Jan;46(1):101-7. doi: 10.1016/j.mcn.2010.08.010. Epub 2010 Aug 31.

PMID:
20807573
44.

Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice.

Tagashira H, Bhuiyan S, Shioda N, Hasegawa H, Kanai H, Fukunaga K.

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1535-45. doi: 10.1152/ajpheart.00198.2010. Epub 2010 Aug 27.

45.

Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions.

Bhuiyan MS, Tagashira H, Shioda N, Fukunaga K.

Expert Opin Ther Targets. 2010 Oct;14(10):1009-22. doi: 10.1517/14728222.2010.509348.

PMID:
20722474
47.

[Donepezil-induced neuroprotection of acetylcholinergic neurons in olfactory bulbectomized mice].

Yamamoto Y, Shioda N, Han F, Moriguchi S, Fukunaga K.

Yakugaku Zasshi. 2010 May;130(5):717-21. Review. Japanese.

48.

Transcriptional upregulation of calcineurin Abeta by endothelin-1 is partially mediated by calcium/calmodulin-dependent protein kinase IIdelta3 in rat cardiomyocytes.

Lu YM, Shioda N, Yamamoto Y, Han F, Fukunaga K.

Biochim Biophys Acta. 2010 May-Jun;1799(5-6):429-41. doi: 10.1016/j.bbagrm.2010.02.004. Epub 2010 Mar 6.

PMID:
20215061
49.

Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain.

Shioda N, Yamamoto Y, Watanabe M, Binas B, Owada Y, Fukunaga K.

J Neurosci. 2010 Feb 24;30(8):3146-55. doi: 10.1523/JNEUROSCI.4140-09.2010.

50.

The induction of reactive oxygen species and loss of mitochondrial Omi/HtrA2 is associated with S-nitrosoglutathione-induced apoptosis in human endothelial cells.

Liu QB, Liu LL, Lu YM, Tao RR, Huang JY, Han F, Lou YJ.

Toxicol Appl Pharmacol. 2010 May 1;244(3):374-84. doi: 10.1016/j.taap.2010.02.004. Epub 2010 Feb 11. Erratum in: Toxicol Appl Pharmacol. 2010 Aug 15;247(1):70. Shioda, Norifumi [removed]; Moriguchi, Shigeki [removed]; Fukunaga, Kohji [removed].

PMID:
20153346

Supplemental Content

Loading ...
Support Center